Clinical trial
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
NCT00287768 · Japan Clinical Cancer Research Organization, Other · Completed
Key facts
| NCT number | NCT00287768 |
|---|---|
| Title | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer |
| Official title | A Phase III Study of Docetaxel and S-1 Versus S-1 in the Treatment of Advanced Gastric Cancer |
| Lead sponsor | Japan Clinical Cancer Research Organization, Other |
| Collaborators | Korean Cancer Study Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | docetaxel + S-1, S-1 |
| Enrollment | 628 |
| Start date | Mar 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Oct 1, 2010 |
| First posted | Feb 7, 2006 |
| Last update posted | Jun 28, 2011 |
| Countries | Japan |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: